1 results match your criteria: "UK and University of Birmingham College of Dental and Medical Sciences[Affiliation]"
Antiplatelet treatment for acute secondary prevention of non-cardioembolic minor stroke / transient ischaemic attack: an update for the acute physician.
Clin Med (Lond)
September 2022
Queen Elizabeth Hospital, Birmingham, UK and University of Birmingham College of Dental and Medical Sciences, Birmingham, UK.
Article Synopsis
- Acute stroke is the leading cause of disability in the UK and a significant global cause of death, particularly affecting patients with minor stroke symptoms who may first encounter healthcare providers.
- Urgent evaluation and treatment are crucial as these patients face a high risk of major health events and death shortly after the stroke occurs.
- The review discusses four antiplatelet therapies—aspirin, clopidogrel, dipyridamole, and ticagrelor—emphasizing aspirin’s early benefits and the enhanced effectiveness of combining aspirin with clopidogrel, while also noting areas for further research to improve treatment strategies.